// company-profile

Sunshine Biopharma Inc. Insider Trading

SBFM

Every SEC Form 4 insider trading filing for Sunshine Biopharma Inc. (SBFM) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorPharmaceutical PreparationsInc.COFilings3Insiders2
// api This Sunshine Biopharma Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=SBFM" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for SBFM in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Sunshine Biopharma Inc. as of 2026-06-30

— stable
Total reported AUM
$348
QoQ change
Reporting period
2026-06-30
#1
SBI Securities Co., Ltd.
CIK 1851815
$340
162 shares
#2
TD Waterhouse Canada Inc.
CIK 1999606
$2
1 shares
#3
Strive Financial Group ,LLC
CIK 2090040
$2
1 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 14, 2026NATAN DAVIDSBFM
Award
100,000$0.00$0K
Mar 4, 2024Slilaty Steve N.SBFM
Purchase
100,000$0.10$10K
Feb 8, 2024Slilaty Steve N.SBFM
Purchase
20,000$0.10$2K